Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | kringle domain-containing protein | 0.175 | 1 | 0.5 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0914 | 0.2741 | 0.2632 |
Brugia malayi | Kringle domain containing protein | 0.175 | 1 | 1 |
Loa Loa (eye worm) | DOMON domain-containing protein | 0.1168 | 0.4949 | 0.4949 |
Schistosoma mansoni | hypothetical protein | 0.175 | 1 | 1 |
Brugia malayi | SEA domain containing protein | 0.1168 | 0.4949 | 0.4949 |
Onchocerca volvulus | 0.1316 | 0.6229 | 0.6229 | |
Loa Loa (eye worm) | hypothetical protein | 0.1316 | 0.6229 | 0.6229 |
Onchocerca volvulus | 0.1168 | 0.4949 | 0.4949 | |
Plasmodium falciparum | cysteine repeat modular protein 1 | 0.175 | 1 | 0.5 |
Echinococcus multilocularis | tissue type plasminogen activator | 0.175 | 1 | 0.5 |
Onchocerca volvulus | 0.1168 | 0.4949 | 0.4949 | |
Onchocerca volvulus | 0.175 | 1 | 1 | |
Onchocerca volvulus | 0.1168 | 0.4949 | 0.4949 | |
Leishmania major | hypothetical protein, conserved | 0.175 | 1 | 0.5 |
Brugia malayi | Muscle positioning protein 4 | 0.1316 | 0.6229 | 0.6229 |
Loa Loa (eye worm) | hypothetical protein | 0.175 | 1 | 1 |
Onchocerca volvulus | 0.1168 | 0.4949 | 0.4949 | |
Loa Loa (eye worm) | TK/ROR protein kinase | 0.175 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0757 | 0.1373 | 0.1373 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.175 | 1 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.1168 | 0.4949 | 0.4873 |
Plasmodium vivax | cysteine repeat modular protein 1, putative | 0.175 | 1 | 0.5 |
Echinococcus granulosus | tissue type plasminogen activator | 0.175 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.1168 | 0.4949 | 0.4949 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.